Applications of nanoparticles for diagnosis and therapy of cancer

• Published in: British journal of radiology Vol. 88; no. 1054; p. 20150207
• Main Authors: Baetke, S C, Lammers, T, Kiessling, F
• Format: Journal Article
• Language: English
• Published: England The British Institute of Radiology 01.10.2015
• Subjects: Antineoplastic Agents - administration & dosage; Antineoplastic Agents - therapeutic use; Diagnostic Imaging - methods; Drug Delivery Systems - methods; Humans; Nanomedicine - methods; Nanoparticles - administration & dosage; Nanoparticles - therapeutic use; Neoplasms - diagnosis; Neoplasms - therapy; Other
• ISSN: 0007-1285; 1748-880X
• DOI: 10.1259/bjr.20150207

During the last decades, a plethora of nanoparticles have been developed and evaluated and a real hype has been created around their potential application as diagnostic and therapeutic agents. Despite their suggestion as potential diagnostic agents, only a single diagnostic nanoparticle formulation, namely iron oxide nanoparticles, has found its way into clinical routine so far. This fact is primarily due to difficulties in achieving appropriate pharmacokinetic properties and a reproducible synthesis of monodispersed nanoparticles. Furthermore, concerns exist about their biodegradation, elimination and toxicity. The majority of nanoparticle formulations that are currently routinely used in the clinic are used for therapeutic purposes. These therapeutic nanoparticles aim to more efficiently deliver a (chemo-) therapeutic drug to the pathological site, while avoiding its accumulation in healthy organs and tissues, and are predominantly based on the "enhanced permeability and retention" (EPR) effect. Furthermore, based on their ability to integrate diagnostic and therapeutic entities within a single nanoparticle formulation, nanoparticles hold great promise for theranostic purposes and are considered to be highly useful for personalizing nanomedicine-based treatments. In this review article, we present applications of diagnostic and therapeutic nanoparticles, summarize frequently used non-invasive imaging techniques and describe the role of EPR in the accumulation of nanotheranostic formulations. In this context, the clinical potential of nanotheranostics and image-guided drug delivery for individualized and improved (chemo-) therapeutic interventions is addressed.